BioCryst Pharmaceuticals
BCRX
#5073
Rank
A$2.41 B
Marketcap
A$11.49
Share price
-3.07%
Change (1 day)
-5.48%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Net assets

Net assets on the balance sheet as of September 2025 : -A$0.59 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has -A$0.59 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BioCryst Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-A$0.77 Billion14.44%
2023-12-31$-A$0.67 Billion54.45%
2022-12-31$-A$0.44 Billion193.36%
2021-12-31$-A$0.15 Billion489.1%
2020-12-31$-A$25.06 Million-145.85%
2019-12-31$A$54.63 M-21.83%
2018-12-31$A$69.88 M-34.86%
2017-12-31$A$0.10 B4801.29%
2016-12-31$A$2.18 M-96.66%
2015-12-31$A$65.51 M-29.12%
2014-12-31$A$92.41 M-7421.09%
2013-12-31$-A$1.27 Million188.95%
2012-12-31$-A$0.44 Million-103.03%
2011-12-31$A$14.43 M-77.61%
2010-12-31$A$64.48 M-32.85%
2009-12-31$A$96.03 M45.93%
2008-12-31$A$65.8 M-11.36%
2007-12-31$A$74.23 M176.63%
2006-12-31$A$26.83 M-66.4%
2005-12-31$A$79.86 M110.7%
2004-12-31$A$37.9 M-0.95%
2003-12-31$A$38.27 M-46.27%
2002-12-31$A$71.22 M-36.02%
2001-12-31$A$0.11 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Repligen
RGEN
A$3.15 B-637.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$1.99 B-440.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
A$11.37 M-101.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-A$0.24 Billion-59.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$32.47 B-5,631.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.90 B-254.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$32.05 B-5,559.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
A$0.88 B-250.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A$10.63 M-101.81%๐Ÿ‡บ๐Ÿ‡ธ USA